Connect with us

Stock Market

Dangote Cement Grows Profit to N65.55 Billion in Q2 2020



Dangote Cement Posts N65.55 Billion Profit After Tax in Q2 2020

Dangote Cement Plc, Nigeria’s most capitalised listed company, on Friday reported a strong second quarter (Q2) earnings despite the ongoing economic headwinds.

In the unaudited financial statement released through the Nigerian Stock Exchange, the cement manufacturing company grew revenue from N227.573 billion filed in the same period of 2019 to N227.670 billion in the second half of 2020.

The production cost of sales rose from N93.69 billion achieved in Q2 2019 to N98.095 billion in Q2 2020. While the company’s gross profit declined slightly from N133.879 billion in the corresponding period of 2019 to N129.575 billion in Q2 2020.

Dangote cement reported an increase in administrative expenses from N11.75 billion in Q2 2019 to N13.214 billion in Q2 2020. Profit from operating activities fell slightly from N82.144 billion in Q2 2019 to N81.700 billion in Q2 2020.

Profit before tax slid marginally from N76.528 billion achieved in Q2 2019 to N74.794 billion Q2 2020.

However, because income tax paid by Dangote Cement Plc in the second quarter declined from N17.542 billion in Q2 2019 to N9.243 billion in Q2 2020. The company was able to record positive better profit after tax of N65.551 billion, up from N58.986 billion reported in the corresponding quarter of 2019.

Total assets expanded to N1.805 trillion in the quarter under review from N1.741 trillion in the same quarter of 2019.

Similarly, total liability increased from N843,414 billion in Q2 2019 to N1.066 trillion in Q2 2020.

Total equity, however, decreased from N897.937 billion in Q2 2019 to N739.367 billion in Q2 2020.

Earnings per share also improved from N3.47 in Q2 2019 to N3.85 in Q2 2020.

CEO/Founder Investors King Ltd, a foreign exchange research analyst, contributing author on New York-based Talk Markets and, with over a decade long experience in the global financial market.

Continue Reading

Stock Market

Stock Market Gains on Monday Despite Dangote Sugar, UACN, AIICO Closing lower



stock 1

Stock Market Gains Slightly  on Monday

The Nigerian Stock Exchange closed slightly higher on Monday as stocks of Flour Mill, BUA Cement, GTbank and others boosted the Exchange.

The market capitalisation of listed equities expanded to N12.919 trillion while the NSE All-Share Index gained 0.29 percent to 24,766.2 basis points.

Investors traded 186.472 million shares valued at N1.309 billion during the trading hours of Monday.

Top Trades by Volume

Symbols Volume Value
TRANSCORP 23,385,372 N14,348,320.96
CUSTODIAN 19,137,859 N97,724,452.45
GUARANTY 18,172,525 N411,609,101.25
FBNH 13,534,675 N69,701,344.55
UBA 9,715,385 N60,519,664.65

Top Gainers

Symbols Last Close Current Change %Change
FLOURMILL N17.05 N18.75 1.7 9.97%
BUACEMENT N39.4 N40.2 0.8 2.03%
GLAXOSMITH N4.9 N5.3 0.4 8.16%
GUARANTY N22.5 N22.85 0.35 1.56%
NEIMETH N1.5 N1.65 0.15 10.00%

Top Losers

Symbols Last Close Current Change %Change
UACN N7 N6.3 -0.7 -10.00%
DANGSUGAR N11.95 N11.5 -0.45 -3.77%
CUSTODIAN N5.5 N5.1 -0.4 -7.27%
NEM N2 N1.9 -0.1 -5.00%
AIICO N0.94 N0.85 -0.09 -9.57%


Continue Reading

Stock Market

Stock Market Closed the Week in Green



stock bull

Stock Market Gains N139 Billion this Week

The Nigerian Stock Exchange (NSE) closed the week positive despite Guinness, WAPCO and others closing in the red.

The three-day trading week saw market capitalisation of listed equities expanding by N139 billion from N12.743 trillion it closed on Friday to N12.882 trillion on Wednesday when the Exchange closed for the week.

While market capitalisation of listed stocks gained 266 basis points from 24,427.73 bps it closed last week to 24,693.73 basis points on Wednesday.

On Wednesday, Investors traded 101.587 million shares valued at N973.637 million in 3,685 transactions. See the details below.

Top Trades

Symbols Volume Value
GUARANTY 10,868,529 N244,682,665.15
FBNH 9,715,949 N49,141,768.40
UBA 9,446,483 N58,597,587.70
ETI 6,081,250 N25,427,858.35
STERLNBANK 5,870,265 N6,990,621.07

Top Gainers

Symbols Last Close Current Change %Change
SEPLAT N282 N310.2 28.2 10.00%
BUACEMENT N39 N39.4 0.4 1.03%
UACN N6.8 N7 0.2 2.94%
PZ N3.9 N4.1 0.2 5.13%
GLAXOSMITH N4.8 N4.9 0.1 2.08%

Top Losers

Symbols Last Close Current Change %Change
GUINNESS N13.5 N13 -0.5 -3.70%
WAPCO N12 N11.75 -0.25 -2.08%
STUDPRESS N1.99 N1.8 -0.19 -9.55%
ARBICO N1.54 N1.39 -0.15 -9.74%
NPFMCRFBK N1.31 N1.18 -0.13 -9.92%


Continue Reading

Stock Market

Why Kodak Stock Gains Over 1500%, Why You Should be Careful



Kodak pix

Kodak Stock Jumps Over 1500%, Here is Why You Should be Careful

Shares of Kodak jumped more than 1,500 percent in the last four days following approval of $765 million loan by the US government to the former photography industry leader to start manufacturing pharmaceutical products.

While the move by Donald Trump-led administration was to make U.S self-sufficient in pharmaceutical drugs and reduce U.S. reliance on foreign sources that were almost grounded by COVID-19 pandemic, the relatively affordable value of Kodak stock was what boosted its attractiveness among retail investors that jumped on it through various trading apps like Robinhood.

Kodak opened at $2.15 per share on Monday and quickly rose by over 500 percent on Tuesday after Jim Continenza, the Chief Executive Officer, Kodak, made the loan approval public.

This continues until Thursday morning when the stock hit $41.48. Gaining more than 1,500 percent with market capitalisation hitting as high as $1.75 billion from less than $115 million it opened the week.


Therefore, the stock value rose based on the news and affordability alone without any known product or strong fundamentals in an industry where a failed trial can derail any hype.

This was similar to what happened earlier in the year when the stock of Hertz jumped to unpredictable highs despite the company filing Chapter 11. Retail investors jumped on the stock after report of its bankruptcy plummeted its value, making it affordable to retail investors that kept jumping on it via various trading apps and eventually drove the price of a dying company to a record high.

The stock eventually crashed from $20.29 per share to $1.48 per share as at the time of writing.


At Investors King we believe a similar thing is playing out with Kodak for several reasons, Kodak has no known pharmaceutical product or history with pharmaceutical products rather the struggling photography company is looking to take advantage of unrestrained funds going into the health sector given global pandemic.

While this could eventually work out, Kodak presently lacks the pedigree or necessary tools to compete with top American pharmaceutical companies working hard to address various COVID-19 challenges.

Kodak pix 2

Also, it would take several months or more than a year before Kodak hit the market with any pharmaceutical products. For those Nigerians, using apps to trade American stocks, Egungun be careful o!.

Continue Reading